LXG-6403

N/A

Report date: 2024/07/25 15:06:28
NME

Base Information

Drug NameLXG-6403
Drug Alias NameLXG6403LXG-6403
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionArachidonate 15-lipoxygenase inhibitors
TargetsArachidonate 15-lipoxygenase
Therapy Area/IndicationsTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMedical University Of South Carolina
China Registration ClassN/A

Develop Information

Active CompaniesMedical University Of South Carolina
Inactive CompaniesN/A
Active IndicationsTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A